MedTech Dive June 24, 2022
Nick Paul Taylor

Dive Brief:

  • The value of medical device mergers and acquisitions fell 85% in the first half of this year, compared to a bumper 2021, as companies focused on integration and value capture activities, a PwC report found.
  • PwC went into 2022 expecting another “exceptional” year for healthcare M&A activity, although it predicted companies would make small acquisitions in the first half of the year before moving on to larger deals in the second half. The advisory firm said it still expects activity to pick up in the second half of 2022.
  • Abbott Laboratories, Johnson & Johnson and Medtronic are seeking M&A targets, but PwC highlights a range of barriers that could stop acquisitions, including supply chain issues, scrutiny from...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Medical Devices, Survey / Study, Trends
Related Articles:
Exo adds FDA-cleared AI tools to handheld ultrasound system
FDA spends $1.2M on VR-enabled hub to spur development of at-home care devices
FDA launches initiative to advance home healthcare models, devices
Is Telepathy Possible? Perhaps, Due To New Technology
FDA Proposes Updated Guidance Concerning Cybersecurity of Medical Devices

Share This Article